Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy study of XH-S003 capsules in paroxysmal nocturnal hemoglobinuria
CTR20253152Phase 2Active
- Sponsor
- Xinghao Pengbo
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XH-S003 in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Xinghao Pengbo. Started Aug 2025; status: active.
02
Drugs
XH-S003
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on CTR20253152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253152.